Sanofi Pasteur presents Menactra vaccine safety data at the IDSA

2. November 2009 10:44

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, presented Safety of a Quadrivalent (A,C,Y,W-135) Meningococcal Vaccine When Given to Infants with Other Pediatric Vaccines at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA) this past weekend. [More]

29beb298-1cee-45ab-9390-0718a8001db1|0|.0

Posted in: Child Health News | Pharmaceutical News

Tags: Diphtheria, Headache, Hypersensitivity, Immunization, Measles, Mumps, Vaccine

Women may need smaller dose of H1N1 vaccine

31. October 2009 00:55

THE emergence of the H1N1 swine flu has added urgency to what has become an annual ritual for millions of Americans: getting a flu shot. The good news is that scientists have developed a vaccine against the H1N1 virus. But it is taking much longer than expected to produce the hundreds of millions of doses the government had planned to distribute. And it is still too soon to know how effective the vaccine will be in preventing swine flu. [More]

f44a8b57-5d19-4470-a629-0de8977e5737|0|.0

Posted in: Disease/Infection News | Healthcare News | Pharmaceutical News

Tags: Antibody, H1N1, Herpes, Herpes Simplex, Immunology, Influenza, Measles, Mumps, Swine Flu, Vaccine, Virus, Yellow Fever

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

27. October 2009 06:22

More teenagers are being vaccinated against human papillomavirus (HPV), meningococcal meningitis and pertussis (whooping cough), though the rates are still too low, according to recently released government data and a panel of experts convened by the National Foundation for Infectious Diseases (NFID). [More]

b8e58aee-2bc3-4d88-9ce3-a96bfa2d38f1|0|.0

Posted in: Disease/Infection News | Pharmaceutical News

Tags: Brain, Cancer, CDC, Cervical Cancer, Cough, Diphtheria, Hearing Loss, Hepatitis B, Hospital, Immunization, Influenza, Measles, Meningitis, Mumps, Poverty, Tetanus, Vaccine, Whooping Cough

Merck's sales increases by 2% in third quarter 2009

22. October 2009 08:06

Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-closing merger-related expenses. Third-quarter GAAP EPS was $1.61. [More]

cbc59315-7610-4c1c-8b01-4e77137fb8ca|0|.0

Posted in: Business / Finance

Tags: Antiretroviral, Asthma, Cancer, Cervical Cancer, Diabetes, Gardasil, Gastroenteritis, Herpes, Herpes Zoster, Investment, Losartan, Measles, Metformin, Mumps, Nexium, Potassium, Rhinitis, Rotavirus, Shingles, Type 2 Diabetes, Vaccine, Virus, Vytorin, Zocor, Zolinza

Research rules out link between MMR vaccines and autism

9. October 2009 04:02

A new article recently published in the Journal for Specialists in Pediatric Nursing explored vaccination history, vaccine safety monitoring systems in the U.S., and the two most publicized theoretical vaccine-related exposures associated with autism - the vaccine preservative thimerosal and the measles, mumps, and rubella (MMR) vaccine. [More]

6cf64477-ee39-4610-bab4-5d09ec665b69|2|2.5

Posted in: Medical Condition News | Pharmaceutical News

Tags: Autism, CDC, Immunization, Measles, Mumps, Nursing, Vaccine

Changing trends and developments in the global market for vaccines

25. September 2009 06:34

The global market for human vaccines has experienced strong growth through 2008 and this is expected to continue through the forecast period. Growth will be fueled by new product introductions and rising usage in all regions. [More]

954d8bad-30f6-4904-8bea-62d8ee5d74ac|0|.0

Posted in: Pharmaceutical News

Tags: Allergy, Anthrax, Botulism, Cancer, CDC, Cervical Cancer, Cholera, Diphtheria, DNA, Haemophilus influenzae Type B, Hepatitis B, Hepatitis C, HIV/AIDS, Immunization, Influenza, Japanese Encephalitis, Leishmaniasis, Malaria, Measles, Mumps, Pandemic, Pfizer, Pneumococcal Disease, Polio, Rotavirus, Shingles, Smallpox, Tetanus, Tuberculosis, Tularemia, Typhoid Fever, Vaccine, Virus, West Nile Virus, Yellow Fever

H1N1 infected people continue to shed live virus days after the symptoms

19. September 2009 03:11

ABC News and other outlets are reporting that two studies released on Tuesday suggest that people infected with the H1N1 virus continue to shed virus after the point where current recommendations say they can resume their normal activities. [More]

c39ccc30-c8fc-4beb-b53a-2570c62019fb|0|.0

Posted in: Disease/Infection News

Tags: Biochemistry, Biotechnology, Cancer, CDC, Cell, Cytokines, Diarrhea, Gardasil, H1N1, Hepatitis B, Hospital, Immunology, Influenza, Malaria, Measles, Mumps, Pandemic, Pathology, Rotavirus, Shingles, Telemedicine, Vaccine, Virus

Partnership between Wellcome Trust and Merck & Co

18. September 2009 04:30

The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries. [More]

7872abf6-142d-48a8-a9c4-a85b215c1665|0|.0

Posted in: Business / Finance | Pharmaceutical News

Tags: Allergy, CDC, Health and Human Services, Hepatitis B, Investment, Measles, Mumps, Vaccine

A not-for-profit mission from Wellcome Trust and Merck to develop affordable vaccines for low-income countries

17. September 2009 08:08

The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries. [More]

39961986-3315-4cbb-9830-70d399eb3afd|0|.0

Posted in: Disease/Infection News | Pharmaceutical News

Tags: Allergy, CDC, Health and Human Services, Hepatitis B, Investment, Measles, Mumps, Vaccine

Blue Mountain Hospital implements OpenVista to improve clinical outcomes

17. September 2009 04:40

Medsphere Systems Corporation, the leading provider of open source healthcare IT solutions, today announced the successful implementation of OpenVista, the company's flagship electronic health record (EHR) at the 11-bed Blue Mountain Hospital in Blanding, Utah. [More]

72df27be-9504-484c-9ab4-662f4196d8e3|0|.0

Posted in: Device / Technology News

Tags: Dialysis, Health IT, Hospital, Mumps, Nutrition, Physical Therapy, Radiology, Veterans Affairs

CDC recommends routine health examintion for all school-age children

3. September 2009 23:44

Although school has just begun, it is already exam time for students throughout Wisconsin. That's because in addition to notebook paper and pens, back-to-school preparations should also include routine health exams to make sure students are healthy and ready to learn. These include: a doctor's exam to confirm that all immunizations are up-to-date, a dental exam and a vision exam. [More]

87832e59-a6b2-4a07-84c6-2a1f49187e80|0|.0

Posted in: Child Health News

Tags: CDC, Dentistry, Diphtheria, H1N1, Health Insurance, Immunization, Influenza, Measles, Mumps, Pediatrics, Swine Flu, Tetanus, Vaccine

The Gambia introduces pneumococcal immunisation programme

19. August 2009 21:00

The Gambia, Minister of Health Dr. Mariatou Jallow administered the first dose of the pneumococcal vaccine to Gambian children at a rural clinic outside Banjul today. Joined by the Gambia’s Vice President, Mrs. Isatou Njie-Saidy, Dr. Jallow and hundreds of Gambian citizens celebrated this historic event, which marks the first step in the rollout of the Gambia’s national pneumococcal immunisation programme. [More]

215faaf6-b9a3-4846-976d-f4aff2eb0cb3|0|.0

Posted in: Disease/Infection News | Pharmaceutical News

Tags: Biotechnology, Diarrhea, Diphtheria, Hepatitis B, Hypersensitivity, Kidney Disease, Malaria, Measles, Meningitis, Mumps, Otitis Media, Pneumococcal Disease, Pneumonia, Polio, Sepsis, Sleep, Streptococcus pneumoniae, Vaccine, Vomiting

H1N1 pandemic: no time for complacency

18. August 2009 02:24

Prevention of H1N1 influenza virus through vaccination must be our top priority if disease patterns in the northern hemisphere follow those in the southern hemisphere this fall, writes Paul Hébert, Editor-in-Chief of CMAJ (Canadian Medical Association Journal) in an editorial. [More]

bb06a140-12dc-4d9f-b0e4-013b9295f256|0|.0

Posted in: Disease/Infection News

Tags: H1N1, Immunization, Influenza, Mumps, Pandemic, Swine Flu, Virus

Discovery of potential candidate protein for cancer vaccines

4. August 2009 19:20

Researchers at the University of Pittsburgh School of Medicine have learned that some healthy people naturally developed an immune response against a protein that is made in excess levels in many cancers, including breast, lung, and head and neck cancers. The finding suggests that a vaccine against the protein might prevent malignancies in high-risk individuals. [More]

a9abb011-c96a-4725-aad9-a60d7bf45140|0|.0

Posted in:

Tags: Cancer, Cell, Colon Cancer, Immunology, Lung Cancer, Mumps, Ovarian Cancer, Vaccine, Virus

Xerostomia linked to use of multiple medications

9. July 2009 16:21

Approximately ninety-one percent of dentists say patients complaining about dry mouth are taking multiple medications, according to a nationwide member survey conducted by the Academy of General Dentistry (AGD). [More]

163192bb-8646-4a96-9e21-cf13fbde2637|1|5.0

Posted in: Medical Condition News

Tags: Alzheimer's Disease, Anemia, Antihypertensive Drug, Cystic Fibrosis, Dentistry, Diabetes, HIV/AIDS, Hypertension (High Blood Pressure), Mumps, Parkinson's Disease, Rheumatoid Arthritis, Sjogren's Syndrome, Stroke, Xerostomia

Free!

Recent Comments

Twitter

Information

Mumps News and Research

Sanofi Pasteur presents Menactra vaccine safety data at the IDSA

Women may need smaller dose of H1N1 vaccine

Vaccination rates need improvement; racial and ethnic disparities in vaccination coverage

Merck's sales increases by 2% in third quarter 2009

Research rules out link between MMR vaccines and autism

Changing trends and developments in the global market for vaccines

H1N1 infected people continue to shed live virus days after the symptoms

Partnership between Wellcome Trust and Merck & Co

A not-for-profit mission from Wellcome Trust and Merck to develop affordable vaccines for low-income countries

Blue Mountain Hospital implements OpenVista to improve clinical outcomes

CDC recommends routine health examintion for all school-age children

The Gambia introduces pneumococcal immunisation programme

H1N1 pandemic: no time for complacency

Discovery of potential candidate protein for cancer vaccines

Xerostomia linked to use of multiple medications

Recent Articles

Free!

Recent Comments

Twitter

Information

Mumps News and Research

Medical News Cloud

Recent Articles